槲皮素与吲哚-3-甲醇抑制人子宫平滑肌瘤细胞细胞外基质表达
该体外研究以人子宫肌层细胞和平滑肌瘤细胞为对象,分别用10、50、100、250 µg/ml的槲皮素或吲哚-3-甲醇(I3C)处理48小时,检测细胞外基质(胶原1A1、纤连蛋白、versican)的mRNA和蛋白表达、细胞迁移及增殖。结果显示两者均降低胶原1A1和纤连蛋白表达、抑制迁移和增殖,但不影响versican mRNA,提示其可能作为子宫肌瘤的潜在治疗或预防剂。
要点
- 槲皮素降低子宫肌层和平滑肌瘤细胞中胶原1A1的mRNA水平(P<0.0001)。
- 槲皮素和I3C均抑制子宫肌层与平滑肌瘤细胞的迁移(P<0.05)。
- 两者均显著降低子宫肌层细胞增殖(P<0.05),但未改变versican mRNA。
核心结论
- 槲皮素和I3C在体外表现出抗纤维化、抗迁移和抗增殖作用,为开发子宫肌瘤治疗或预防药物提供了科学依据。
研究设计与样本
- 体外研究:人子宫肌层细胞和平滑肌瘤细胞分别用10、50、100、250 µg/ml的槲皮素或I3C处理48小时。
主要发现
- 槲皮素降低子宫肌层和平滑肌瘤细胞胶原1A1 mRNA(均P<0.0001)。
- 槲皮素降低子宫肌层细胞纤连蛋白mRNA和蛋白(P<0.05),并降低平滑肌瘤细胞纤连蛋白蛋白(P<0.05)。
- I3C在高剂量下降低子宫肌层和平滑肌瘤细胞胶原1A1 mRNA(均P<0.05);最高剂量I3C降低两种细胞纤连蛋白蛋白(P<0.05),但平滑肌瘤细胞mRNA未受影响。
- 槲皮素和I3C均未改变两种细胞的versican mRNA水平。
- 槲皮素和I3C均显著减少子宫肌层和平滑肌瘤细胞迁移(槲皮素P<0.05;I3C子宫肌层P<0.05,平滑肌瘤P<0.01),并降低子宫肌层细胞增殖(P<0.05)。
临床怎么用
- 该体外证据提示槲皮素和I3C可能通过抑制细胞外基质表达、迁移和增殖发挥抗肌瘤作用。
- 目前仅为细胞实验,尚不能直接转化为临床用药推荐。
局限性
- 研究为体外细胞实验,未涉及动物模型或人体临床试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the effect of quercetin and indole-3-carbinol (I3C) on extracellular matrix expression, cell migration and proliferation in human myometrial and uterine leiomyoma cells. DESIGN: Myometrial and leiomyoma cells were treated with quercetin or I3C at different concentrations (10 µg/ml; 50 µg/ml; 100 µg/ml; and 250 µg/ml) for 48 h to measure mRNA and protein expressions of extracellular matrix (collagen 1A1, fibronectin and versican), as well as cell migration and the proliferation rate. RESULTS: Quercetin decreased mRNA levels of collagen 1A1 in myometrial (P < 0.0001) and leiomyoma cells (P < 0.0001). Quercetin reduced mRNA and protein levels of fibronectin in myometrial cells (P < 0.05) and fibronectin protein in leiomyoma cells (P < 0.05). I3C reduced collagen 1A1 mRNA levels in myometrial (P < 0.05) and leiomyoma cells at higher dose (P < 0.05). The protein levels of fibronectin were also reduced in both myometrial and leiomyoma cells with highest dose of I3C (P < 0.05), although mRNA levels were not affected in leiomyoma cells. Neither quercetin nor I3C treatment altered versican mRNA levels in both cell types. A significant reduction of the migration of both myometrial and leiomyoma cells in response to quercetin was observed (P < 0.05) and I3C (P < 0.05 for myometrial and P < 0.01 for leiomyoma cells) treatment. Both quercetin and I3C significantly reduced myometrial cell proliferation (P < 0.05). CONCLUSIONS: The in-vitro anti-fibrotic, anti-migratory and anti-proliferative effects of quercetin and I3C form the scientific basis for developing new therapeutic, preventive agents, or both, for uterine leiomyomas.
引用
- Greco S, Islam MS, Zannotti A, et al. Quercetin and indole-3-carbinol inhibit extracellular matrix expression in human primary uterine leiomyoma cells. Reprod Biomed Online. 2020. PMID: 32276890. doi:10.1016/j.rbmo.2020.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。